Standard-Essential Patents and FRAND Toolkit: Declarations, Licensing, and Injunction Limits

By Casey Scott McKay · 2025-04-08

A product that implements a published standard practices patents nobody can design around, and the entire system rests on a licensing commitment that participants made when the standard was written. This toolkit maps that system - the standards organizations and their policies, the declaration process and why declarations overstate essentiality, the commitment and what it actually binds, and the negotiation framework that has emerged for determining whether each side behaved reasonably. It explains why injunctive relief is constrained against a willing licensee and why that constraint produces the hold-out problem, how royalty base and aggregate burden arguments actually work, what patent pools solve and what they do not, and where antitrust exposure sits for both holders and implementers. It closes with the reading path, the authorities table, and the forms.

IP and Technology > Patent Counseling Transactions | Toolkit | Published 8 April 2025 - Updated 27 April 2025 | Casey Scott McKay - marksy.us

Summary. A product that implements a published standard practices patents nobody can design around, and the entire system rests on a licensing commitment that participants made when the standard was written. This toolkit maps that system — the standards organizations and their policies, the declaration process and why declarations overstate essentiality, the commitment and what it actually binds, and the negotiation framework that has emerged for determining whether each side behaved reasonably. It explains why injunctive relief is constrained against a willing licensee and why that constraint produces the hold-out problem, how royalty base and aggregate burden arguments actually work, what patent pools solve and what they do not, and where antitrust exposure sits for both holders and implementers. It closes with the reading path, the authorities table, and the forms.

Keywords: standard essential patent · standards development organization · intellectual property rights policy · essentiality declaration · frand commitment · willing licensee · negotiation framework · royalty base · smallest salable unit · aggregate royalty burden · patent pools · injunction limits · hold-up · hold-out · antitrust exposure · transfer of commitments · portfolio licensing · essentiality analysis · arbitration · global rate setting

Start Here

Ferridge Devices ships a connected sensor module that implements two wireless standards and one video codec. On a Tuesday, four things happen.

A letter arrives from a patent holder offering a licence to a portfolio of "essential" patents at a per-unit rate that, multiplied across the company's volume, exceeds the module's gross margin.

The engineering team, asked whether the product could avoid the patents, explains that it cannot, because the standard requires the technique.

Procurement discovers that the chipset supplier's terms disclaim any licence to standard-essential patents and push the obligation downstream.

And a customer's contract requires a representation that the product is licensed for all standards it implements.

Four facts, one system, and a common misunderstanding: that this is a clearance problem. It is not. It is a licensing problem with a contractual overlay, and design-around is not an available answer.

This toolkit answers three questions.

What is actually essential, and to what? Declarations overstate essentiality substantially, and the difference between declared and actually essential is where negotiations are won.
What does the commitment require, of whom? A licensing obligation on the holder, and a reciprocal expectation of good faith on the implementer.
What happens if the parties cannot agree? Injunction, damages, rate setting, or arbitration — each with different leverage and different geography.

If you read only one thing, read What a Patent Is Worth in Court. Standard-essential licensing is a valuation argument conducted in the shadow of an injunction that may or may not be available, and the valuation doctrine is the same.

How the System Works

Standards organizations write specifications through participant committees. The specifications become the technical requirement for interoperability, and implementing them is not optional for anyone selling into the ecosystem.

Participants hold patents on the techniques they propose. Without a rule, a participant could contribute a technique, wait for adoption, and then exclude everyone — the hold-up problem the whole system exists to prevent.

The policy solves it with a commitment. Most organizations require participants to disclose patents they believe may be essential and to commit to license them on fair, reasonable, and non-discriminatory terms, or to decline and have the technique excluded from the standard.

The commitment is contractual. It runs to the organization, and implementers are generally treated as third-party beneficiaries able to enforce it.

It travels with the patent. Most policies require a transferee to be bound, and whether a commitment binds a subsequent purchaser who did not agree has been litigated repeatedly. The policy language governs and it varies.

What the policy does not do. It does not set a rate, define essentiality, verify declarations, or resolve disputes. Those are left to the parties and to whatever forum they end up in.

Declarations, and What They Are Worth

What a declaration says. That the participant believes the patent may be or may become essential to the standard. It is a statement of belief, made early, often before claims are finalized.

Why declarations overstate. There is no penalty for over-declaring and there is risk in under-declaring, because a policy may require licensing on more favorable terms or may bar enforcement of an undeclared patent. Rational participants declare broadly.

How much they overstate. Independent essentiality studies consistently find that a large fraction of declared patents are not essential on analysis — expired, not covering any mandatory feature, covering an optional feature nobody implements, or simply not reading on the specification.

What this means in a negotiation. A demand covering "two thousand declared essential patents" is not a demand covering two thousand patents an implementer needs. The essentiality analysis is the implementer's principal tool and it is expensive, which is why holders prefer portfolio pricing.

Sampling. The practical method: select a representative subset, chart each against the specification and against the product, and extrapolate. Both sides do this and the sampling methodology is itself contested.

Mandatory versus optional features. A patent essential to an optional feature the product does not implement is not essential to that product, and this distinction removes a meaningful share of most portfolios.

The Commitment, in Practice

What it obliges the holder to do. Grant a licence on fair, reasonable, and non-discriminatory terms to any implementer who wants one. It does not oblige the holder to accept whatever the implementer offers.

Fair and reasonable. Concerned with the rate and the terms. The recurring arguments are the value of the patented contribution as distinct from the value of standardization itself, apportionment to the smallest salable unit that practices the claim, and the aggregate burden if every holder charged the same.

Non-discriminatory. Concerned with treating similarly situated licensees similarly. It does not require identical rates for everyone; it requires that differences have a justification other than favoritism, and volume, field, and timing are ordinarily acceptable justifications.

What it obliges the implementer to do. Nothing formally, and in practice a great deal, because the willingness of the implementer determines whether an injunction is available.

The negotiation framework. A sequence has emerged from litigation and it is now the reference point in most disputes: the holder notifies the implementer, identifying the patents and how they are infringed; the implementer expresses willingness to take a licence on such terms; the holder makes a written offer with a rate and its justification; the implementer responds promptly, accepting or making a counter-offer with its own justification; and if the counter-offer is rejected, the implementer provides security and accounts for past use.

Why the framework matters. A party that follows it is behaving reasonably; a party that does not supplies the other side's argument. This is the single most useful structure in the entire area, and both sides now negotiate against it explicitly.

Injunctions, Hold-Up, and Hold-Out

The constraint. Where a holder has committed to license and the implementer is willing, injunctive relief is generally unavailable or heavily disfavored, because the holder has agreed to accept money. The equitable analysis under 35 U.S.C. § 283 reflects this.

The hold-up problem it addresses. Without the constraint, a holder could threaten to shut down a product implementing a mandatory standard and extract a payment reflecting the cost of shutdown rather than the value of the technology.

The hold-out problem it creates. An implementer that cannot be enjoined has an incentive to refuse, litigate, and delay, paying nothing meanwhile and risking only a damages award later. The framework's willingness requirement is the answer, and courts increasingly find implementers unwilling where they delay, refuse to counter-offer, or decline to provide security.

Where injunctions remain available. Against an unwilling implementer. Against a party that refuses to be bound by a rate determination it invoked. And in jurisdictions whose practice differs, which is why forum matters enormously.

Exclusion orders at the border are a distinct remedy with a distinct analysis, and the public interest factors there have been applied to standard-essential patents with mixed outcomes.

Anti-suit injunctions. Where parallel proceedings in multiple countries risk inconsistent global rate determinations, courts have issued orders restraining a party from pursuing relief elsewhere, and counter-orders have followed. This is the most volatile area in the field.

Rate Setting

The valuation question. What is a fair and reasonable rate for this portfolio, for this product, in this market?

Comparable licences are the primary evidence, subject to the usual difficulties: portfolio licences covering many patents, licences negotiated under litigation pressure, cross-licences with no cash rate, and licences reflecting a different product mix.

Top-down. Estimate the aggregate royalty that should be paid by an implementer for all essential patents on the standard, then allocate to this holder by its share of essential patents. Attractive in theory and contested at every step: what the aggregate should be, how to count essential patents, and whether all patents are equally valuable.

Bottom-up. Value this holder's specific contributions to the standard directly, through comparable licences or through the technical importance of the contributions. More faithful to the patents in suit and harder to establish.

The royalty base. The recurring fight. A rate on the end product produces a very different number from the same rate on the chipset that implements the standard, and the apportionment principle points toward the smallest salable unit that practices the claim. Holders resist because the component's value understates the technology's contribution; implementers insist because the alternative captures value the patents did not create.

Global versus national rates. A holder with a worldwide portfolio and an implementer selling worldwide frequently want a global rate, and some courts will set one — which raises the question of whether a national court should determine rates for foreign patents, and produces the parallel-proceedings problem.

Arbitration. Increasingly used, because a neutral rate determination binding both parties resolves the hold-up and hold-out problems simultaneously. Its weakness is that both parties must agree to it, and the party with leverage rarely does.

Patent Pools

What they do. Aggregate essential patents from many holders and license them together at a published rate, with revenue allocated among contributors.

Why implementers like them. One transaction, a known rate, and coverage of a substantial share of the essential patents on a standard.

Why they are incomplete. Not every holder joins, and the ones who stay out are frequently the ones with the strongest portfolios and the highest demands. A pool licence reduces the problem; it rarely eliminates it.

Essentiality review. Reputable pools use independent evaluators to assess whether a submitted patent is essential, which makes pool membership a signal of essentiality that a bare declaration is not.

Antitrust considerations. Pools aggregating competing rather than complementary technologies, or including non-essential patents, or facilitating information exchange among competitors, raise real concerns. Well-run pools address this with essentiality review, independent administration, and non-exclusive licensing that leaves members free to license separately. 15 U.S.C. § 1.

The practical instruction for an implementer. Take the pool licence where one exists and covers meaningful ground, then negotiate individually with the holders who stayed out. This is nearly always cheaper than negotiating with everyone.

Antitrust Exposure

For holders. Deceiving a standards organization about patent holdings to capture the standard, then demanding supracompetitive royalties, has been treated as an antitrust violation and as an unfair method of competition. Refusing to license, or licensing on discriminatory terms after committing not to, raises exposure under 15 U.S.C. § 2 and under 15 U.S.C. § 45. Tying essential patents to non-essential ones raises separate questions.

For implementers. Coordinated refusal to license — buyers agreeing among themselves on what they will pay — is a buyer-side cartel problem under 15 U.S.C. § 1, and joint negotiation groups need careful structuring.

Within standards organizations. Participants are competitors meeting to agree on technical requirements, which is lawful and which requires discipline about what else is discussed. Rate discussions among participants are the obvious hazard.

The enforcement posture has moved. Agency views on whether standard-essential patent disputes are properly antitrust matters or contract matters have shifted more than once, and practitioners should treat guidance more than a few years old with caution.

Ferridge's Four Facts, Answered

The letter. Do not accept the portfolio framing. Ask for the claim charts, identify which patents are declared essential to which standard and which feature, determine whether the features are mandatory or optional, and sample the portfolio for actual essentiality. A demand covering hundreds of declared patents typically resolves to a much smaller set that reads on the product.

The design-around answer. Correct, and it is the reason the commitment exists. Frame the negotiation around the commitment rather than around avoidance, and follow the framework precisely — express willingness, respond promptly, counter with a justified rate, and provide security if the counter is rejected. Every step is evidence of willingness and willingness is what keeps an injunction unavailable.

The supplier's disclaimer. Common and consequential. A chipset supplier that disclaims standard-essential licensing is telling the customer it bears the obligation, and the exhaustion argument — that an authorized sale of the chipset exhausts the patents practiced by it — depends on whether the supplier was licensed for that purpose. Read the supply agreement, ask the supplier what licences it holds, and price the answer.

The customer representation. A warranty that the product is licensed for all standards it implements is a warranty nobody can give while negotiations are open. The negotiable position is a representation about pool licences actually held, an indemnity with defined procedures, and an obligation to pursue licences diligently.

Building the Program

Know which standards the products implement, maintained as a register per product line. Companies routinely cannot answer this.

Distinguish mandatory from optional features in each standard, because optional features the product does not implement remove patents from the analysis.

Take the pool licences that cover meaningful ground.

Maintain a holder map — who has declared, who is active, who is in a pool, who has sued.

Budget for it. Standard-essential royalties are a cost of goods rather than a legal contingency, and treating them as an unexpected legal event is how they arrive as a crisis.

Follow the framework from the first letter. Willingness is established by conduct across a correspondence, not by a statement at the end.

Read the supply chain terms for disclaimers, indemnities, and what licences suppliers actually hold.

Participate in the standards work if the company contributes technology, and understand the policy obligations that attach — including disclosure duties that bind from the moment of participation.

Running the Essentiality Analysis

The single most valuable exercise available to an implementer, and the one holders least want performed.

Get the specification. Standards documents are copyrighted and available for purchase or through membership. Reproducing them is a separate question from implementing them.

Identify what the product implements. Which version of the standard, which profiles, which optional features. A product implementing a subset practices a subset of the essential patents.

Get the declaration data. Standards organizations maintain public databases of declared patents, searchable by standard and by holder. They are the starting point and they are not evidence of essentiality.

Screen mechanically first. Remove expired patents, abandoned applications, patents declared to standards the product does not implement, and patents declared to optional features not implemented. This removes a substantial fraction before any technical work.

Sample the remainder. Select a representative subset — by holder, by standard section, by declaration date — large enough to support extrapolation.

Chart each sample against the specification. Does the claim read on something the specification requires? A claim reading on a permitted implementation choice is not essential; a claim reading on a mandatory requirement is.

Then chart against the product. Essential to the standard and practiced by this product are different questions, and the second is the one that matters.

Check validity on the ones that survive. A declared patent that would not withstand a challenge is a different negotiating proposition, and 35 U.S.C. § 311 supplies a route where the art is documentary.

Document the methodology. The sampling approach, the criteria, and the results. The methodology will be attacked and a defensible one is worth more than a favorable one.

Expect the number to fall substantially. A portfolio of hundreds of declared patents routinely resolves to a modest number that are essential, valid, and practiced by the product. That number is what the negotiation should be about.

The Correspondence Record

Willingness is established by conduct across an exchange of letters, and both sides are building a record from the first one.

The holder's first letter should identify the standard, identify the patents, explain how they are essential, and explain how the product infringes. A letter demanding a licence to an unspecified portfolio is a weak first step and it is the most common one.

The implementer's response should be prompt, should express willingness to take a licence on fair terms, and should request the information needed to evaluate the demand — claim charts, the essentiality basis, and comparable licences. Silence is the single worst response available.

The holder's offer should state a rate, a base, and a justification, ideally with comparable licences. An offer with no explanation invites the argument that the holder is not negotiating in good faith.

The implementer's counter-offer should be a real number with a real justification, not a rejection. A counter-offer of a token amount with no analysis is treated as refusal.

Security. Where the counter-offer is rejected, providing security and accounting for past use is what distinguishes a willing licensee from a hold-out, and it is increasingly the decisive fact.

Throughout. Respond within weeks rather than months. Do not go silent. Do not raise validity as a reason to refuse a licence, because a party may challenge validity and still be willing. And assume every letter will be read by a court assessing whether each side behaved reasonably, because it will be.

Exhaustion and the Supply Chain

Where in the chain a licence sits determines who pays, and the answer is contested in nearly every industry that uses standards.

The component-level argument. An implementer buys a chipset that implements the standard. If the chipset maker is licensed, an authorized sale exhausts the patents practiced by the chipset, and the device maker owes nothing more for what the chipset does.

Why holders resist it. Licensing at the component level captures a royalty on a low-value part rather than on the device, which reduces revenue substantially. Holders therefore license at the device level and decline to license component makers, or license them on terms limited to their own manufacture without exhausting downstream.

Why implementers press it. A single licence at the component level is administratively simple, avoids duplicate royalties across a chain, and produces a base that reflects the technology's actual locus.

What the supply agreement says. Frequently that the supplier grants no licence to standard-essential patents and that the customer bears the obligation. Read it, because it is dispositive of the commercial allocation whatever the doctrine says.

Have-made rights. Where the implementer is licensed, a have-made right permits contract manufacture. Its absence means a company that outsources manufacturing has a licence its manufacturer cannot use.

Downstream customers. A device maker's customers — integrators, distributors, and end users — are separately exposed unless the licence covers them. A licence granted to a manufacturer that does not extend downstream leaves the channel unlicensed.

The practical instruction. Map the chain, determine who is licensed for what, read the supply and distribution agreements for licence grants and disclaimers, and price the gaps. This is a contracts exercise more than a patent one and it is where the money actually moves.

Where This Is Heading

Four trajectories are visible and each affects planning.

Rate determination is globalizing. Courts in several jurisdictions have shown willingness to set worldwide rates, on the reasoning that a global portfolio and a global business call for one licence. The consequence is a race to a favorable forum and the anti-suit litigation that follows, and this is the least settled area in the field.

Essentiality verification is becoming institutional. Independent essentiality assessment, pilot programs at standards organizations, and third-party evaluation services all reduce the information asymmetry that has driven portfolio pricing. A world where declarations are verified is a world where negotiations look different.

The component-level question will be resolved, one way or another, and it moves a great deal of money. Practitioners should track it as the single most consequential open issue.

Regulatory attention oscillates. Agency positions on whether these disputes are contract matters or competition matters have shifted repeatedly, and enforcement priorities have followed. Guidance more than a few years old should be treated as historical.

What is stable. The commitment, the negotiation framework, the apportionment principle, and the fact that a product implementing a standard cannot design around. Everything built on top of those has moved and will move again, and a practitioner who holds the four constants can absorb the rest.

Advising the Holder

Most of this toolkit reads from the implementer's chair. The holder's problems are different and equally real.

The commitment binds you. A patent declared essential and committed cannot be used to exclude a willing implementer, and the leverage a patent ordinarily supplies is largely gone. This should inform the decision to participate in standards work at all, because contributing technology to a standard trades exclusivity for ubiquity.

Declare carefully. Over-declaring is rational under most policies and it weakens every negotiation, because an implementer's essentiality analysis will find the overstatement and use it. A portfolio where a high proportion of declared patents survive analysis negotiates from a much stronger position.

Notify properly. The framework's first step is a notification identifying the patents and explaining infringement. A letter that does neither starts the record badly and it is the most common opening.

Make a real offer with a real justification. Comparable licences, an apportionment analysis, and a stated base. An offer with no explanation invites a finding that the holder did not negotiate in good faith and it can carry antitrust exposure under 15 U.S.C. § 2.

Treat similarly situated licensees similarly, and document the justifications where rates differ. Volume, field, timing, and cross-licence value are all defensible; favoritism is not.

Do not tie non-essential patents to the essential ones as a condition, and do not condition a licence on a grant-back broader than the policy contemplates.

Watch the transfer. Selling a committed patent to an entity that has not agreed to be bound is a transaction that policies increasingly prohibit and that courts scrutinize. 35 U.S.C. § 261. An acknowledgment of the commitment in the assignment is the minimum.

Consider arbitration. A neutral rate determination resolves hold-out and it costs the holder the injunction leverage it may not have had anyway.

And be honest with the business. A standard-essential portfolio generates licensing revenue at rates constrained by the commitment. It is not the exclusion asset that an unencumbered patent on the same technology would have been, and companies that contributed to standards expecting otherwise are consistently disappointed.

Patent Pools, Evaluated

Pools are the most efficient mechanism available to an implementer and they are frequently misjudged in both directions.

What to check before joining. Coverage — what share of the essential patents on the standard the pool actually holds, and which significant holders are outside it. Rate — per unit, per product category, with caps. Terms — field of use, territory, term, and whether the licence extends downstream to customers. And whether the pool's essentiality review is genuine or nominal.

The coverage question is the important one. A pool holding a large share of a standard's essential patents removes most of the problem. One holding a small share removes little while establishing a rate benchmark the outside holders will use against the implementer.

The rate benchmark effect. Joining a pool at a published rate tells every outside holder what the implementer has already paid, and they will price against it. This cuts both ways — it also establishes what the implementer regards as reasonable, which is useful in a later dispute.

Retroactive coverage. Whether the pool licence covers past sales, and on what terms. This is frequently the more expensive half of the negotiation.

Multiple pools per standard exist for some standards, with overlapping and competing coverage, and joining several is sometimes necessary.

For a holder considering contributing, the trade is administrative simplicity and broad uptake against a lower per-unit rate and a loss of control over terms. Holders with strong portfolios stay out; holders with breadth rather than depth do better inside.

Antitrust hygiene. A pool limited to complementary essential patents, with independent essentiality evaluation, non-exclusive licensing, and no rate coordination among members outside the pool, is on solid ground. One that aggregates substitutes or includes non-essential patents is not. 15 U.S.C. § 1.

The Aggregate Burden Argument

The most powerful and least tractable argument available to an implementer, and it belongs in every negotiation.

The premise. If every holder of a patent essential to a standard charged the rate this holder is demanding, the total royalty on the product would exceed some plainly unreasonable fraction of its price — sometimes exceeding the price itself.

Why it is compelling. It exposes that a rate defensible in isolation is indefensible in aggregate, and standards involve dozens or hundreds of holders.

Why it is difficult. The aggregate is unknowable with precision. Nobody knows how many patents are truly essential, how many holders will actually demand payment, or what the others are charging, because most licences are confidential.

How it is used anyway. As a sanity check on the top-down analysis, and as a rhetorical frame that shifts the burden onto the holder to explain why its share of a plausible aggregate should be this large.

The holder's answers. That not every holder demands payment. That the implementer should negotiate the aggregate down with everyone rather than singling out this holder. And that the implementer's own conduct — cross-licences, pool memberships, and refusals — affects what it actually pays.

The reconciliation. Both sides are right about something. Aggregate burden is real and it is the reason apportionment matters; it is also not a rate-setting mechanism because the inputs are unavailable. Its practical use is to constrain the plausible range, and courts setting rates use it exactly that way.

A Suggested Reading Path

If a demand has arrived:

If you are clearing a product:

If you hold the patents:

Primary Authorities

| Authority | Proposition | |---|---| | 35 U.S.C. § 271 | Infringing acts | | 35 U.S.C. § 283 | Injunctive relief; the equitable constraint | | 35 U.S.C. § 284 | Damages; reasonable royalty | | 35 U.S.C. § 285 | Fees in exceptional cases | | 35 U.S.C. § 286 | Six-year limitation | | 35 U.S.C. § 287 | Marking and notice | | 35 U.S.C. § 282 | Presumption of validity; defenses | | 35 U.S.C. § 261 | Assignment; transfer of committed patents | | 35 U.S.C. § 311 | Inter partes review; challenging essentiality claims | | 15 U.S.C. § 1 | Restraints of trade; pools and joint negotiation | | 15 U.S.C. § 2 | Monopolization; refusal and discrimination | | 15 U.S.C. § 45 | Unfair methods of competition | | Fed. R. Civ. P. 65 | Injunctions; anti-suit relief | | Fed. R. Evid. 702 | Expert testimony on rates and essentiality |

Forms and Templates

The License Agreement Template is the working document here, and standard-essential licensing stresses several of its provisions unusually: the field and territory definitions determine whether a global rate is being set, the reporting and audit provisions matter because per-unit royalties on high volumes create real accounting obligations, and the change-of-control provision matters because commitments travel with patents and licensees want certainty about who they will be paying. The Portfolio Inventory Template doubles as the standards register — which products implement which standards, which pools are licensed, and which holders remain outstanding. The Cease and Desist Template is worth reading from both sides, because the framework's first step is a notification whose specificity is later assessed. The Assignment Agreement Template should carry an express acknowledgment of standards commitments where committed patents are transferred.

Related Toolkits and Checklists

For the clearance exercise that standard-essential analysis sits alongside, the Freedom-to-Operate and Patent Clearance Toolkit covers the patents a product can design around. For the valuation doctrine the rate arguments apply, the Patent Damages and Remedies Toolkit supplies the apportionment framework. Where a declared patent looks weak, the PTAB Practice Toolkit covers the challenge. Where the negotiation fails, the Patent Litigation Toolkit takes over. And for the licensing mechanics themselves, the Patent Licensing and Technology Transfer Toolkit supplies the terms.